Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_588b860e6b38b90727d63055e8773ce9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_82fd33c16b8449ca7a76fd1144b55513 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d21cbff64022f95c237c0bd3ec8656ca http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d4e89de0272c720d2c4e33f8f3251539 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-0005 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00 |
filingDate |
2019-04-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5e6ef9f8b310cc27a8bf807ab31062b9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6d2deea2e3690fe99c29221987002143 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c1909de658d7a87db06012564f0bf735 |
publicationDate |
2020-10-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-2020204923-A2 |
titleOfInvention |
Thromboxane receptor-based vaccine for managing thrombogenesis |
abstract |
A vaccine against TPR's ligand binding domain, namely the C-terminus of the second extracellular loop (C-EL2), inhibits platelet activation and thrombus formation, without exerting any effects on hemostasis. |
priorityDate |
2019-04-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |